לטרוזול טבע ®

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

LETROZOLE 2.5 MG

Доступно од:

TEVA PHARMACEUTICAL INDUST.LTD

АТЦ код:

L02BG04

Фармацеутски облик:

TABLETS

Пут администрације:

PER OS

Произведен од:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Терапеутска група:

LETROZOLE

Терапеутске индикације:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Датум одобрења:

2010-01-01